Carl Zeiss Meditec AG
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers products and …
Medical - Instruments & Supplies
DE, Jena [HQ]
Financials
Analysts
Wall Street · Earnings · Institutional SentimentA comprehensive analysis section that covers unveiling insights about Carl Zeiss Meditec AG's gradings, price targets and earnings estimates.
Earnings
See the historical earnings and what wall street
analysts forecasted and
forecast for
future earnings.
Reported
Past Estimate Consensus
Future Estimate Consensus
| FY | EPS | Revenue [mil.] | Profit [mil.] | EBITDA [mil.] | EBIT [mil.] | Expenses · SGA [mil.] | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E | E | E | E | E | E | |||||||
| 2015 | - | 1.082 | - | 1,125 | - | 96 | - | 256 | - | 214 | - | 275 |
| 2016 | - | 1.329 | - | 1,236 | - | 118 | - | 281 | - | 235 | - | 302 |
| 2017 | - | 1.699 | - | 1,389 | - | 151 | - | 316 | - | 264 | - | 340 |
| 2018 | - | 1.715 | - | 1,494 | - | 153 | - | 340 | - | 284 | - | 365 |
| 2019 | - | 2.145 | - | 1,573 | - | 191 | - | 358 | - | 299 | - | 385 |
| 2020 | - | 1.498 | - | 1,587 | - | 134 | - | 361 | - | 301 | - | 388 |
| 2021 | - | 3.214 | - | 1,909 | - | 287 | - | 434 | - | 363 | - | 467 |
| 2022 | - | 2.778 | - | 1,798 | - | 248 | - | 409 | - | 342 | - | 440 |
| 2023 | - | 3.131 | - | 2,214 | - | 280 | - | 504 | - | 421 | - | 541 |
| 2024 | - | 2.077 | - | 2,308 | - | 185 | - | 525 | - | 439 | - | 564 |
| 2025 | - | 2.757 | - | 2,484 | - | 246 | - | 566 | - | 472 | - | 608 |
| 2026 | - | 3.412 | - | 2,677 | - | 2.F11X/td> | - | 2.F111/td> | - | 2.F111 | - | 2.F111 |
| 2027 | - | 4.014 | - | 2,921 | - | 1.F12X/td> | - | 1.F121/td> | - | 1.F121 | - | 1.F121 |
| 2028 | - | 4.651 | - | 3,132 | - | 0.F13X/td> | - | 0.F131/td> | - | 0.F131 | - | 0.F131 |
Institutional Sentiment
Wall Street · Earnings · Institutional Sentiment
Morgan Stanley
1Y Ago:
n/a
Prev. Grade
n/a
Latest
n/a
JP Morgan Chase
1Y Ago:
n/a
Prev. Grade
n/a
Latest
n/a
Citigroup
1Y Ago:
n/a
Prev. Grade
n/a
Latest
n/a
Overall Consensus
Grading Consensus
Click to each, to see the gradePrice Target Consensus
Nov. 6, 2024Price Then
$64.71
Price Target
$n/a
Price Now
$61.22